Tedizolid for the Management of Human Infections: In Vitro Characteristics

Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically

Ferraro, M. J. (2000) · Cited by 16,875

Clinical and Laboratory Standards Institute

Gressner, A. M., & Arndt, T. (2019) · Springer Reference Medizin · doi:10.1007/978-3-662-48986-4_300416 · Cited by 5,092

Linezolid resistance in a clinical isolate of Staphylococcus aureus

Tsiodras, S., Gold, H. S., Sakoulas, G., Eliopoulos, G. M., Wennersten, C. B., Venkataraman, L., Moellering, R. C., & Ferraro, M. J. (2001) · The Lancet · doi:10.1016/s0140-6736(01)05410-1 · Cited by 1,034

Infections due to vancomycin-resistant Enterococcus faecium resistant to linezolid

Gonzales, R. D., Schreckenberger, P. C., Graham, M. B., Kelkar, S., DenBesten, K., & Quinn, J. P. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04376-2 · Cited by 542

Development of in vitro susceptibility testing criteria and quality control parameters

Novick, W. J. (1989) · Clinical Microbiology Newsletter · doi:10.1016/0196-4399(89)90068-8 · Cited by 409

Resistance to Linezolid Caused by Modifications at Its Binding Site on the Ribosome

Long, K. S., & Vester, B. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.05702-11 · Cited by 377

Tedizolid Phosphate vs Linezolid for Treatment of Acute Bacterial Skin and Skin Structure Infections

Prokocimer, P., Anda, C. S. D., Fang, E., Mehra, P., & Das, A. (2013) · JAMA · doi:10.1001/jama.2013.241 · Cited by 362

Identification of a Plasmid-Borne Chloramphenicol-Florfenicol Resistance Gene in Staphylococcus sciuri

Schwarz, Š., Werckenthin, C., & Kehrenberg, C. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.9.2530-2533.2000 · Cited by 342

Acquisition of a natural resistance gene renders a clinical strain of methicillin‐resistant Staphylococcus aureus resistant to the synthetic antibiotic linezolid

Toh, S., Xiong, L., Arias, C. A., Villegas, M. V., Lolans, K., Quinn, J., & Mankin, A. S. (2007) · Molecular Microbiology · doi:10.1111/j.1365-2958.2007.05744.x · Cited by 338

The emerging problem of linezolid-resistant Staphylococcus

Gu, B., Kelesidis, T., Tsiodras, S., Hindler, J. A., & Humphries, R. M. (2012) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dks354 · Cited by 332

The Site of Action of Oxazolidinone Antibiotics in Living Bacteria and in Human Mitochondria

Leach, K. L., Swaney, S. M., Colca, J. R., McDonald, W. G., Blinn, J. R., Thomasco, L. M., Gadwood, R. C., Shinabarger, D. L., Xiong, L., & Mankin, A. S. (2007) · Molecular Cell · doi:10.1016/j.molcel.2007.04.005 · Cited by 278

The oxazolidinones: past, present, and future

Shaw, K. J., & Barbachyn, M. R. (2011) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2011.06330.x · Cited by 259

MRSA: the first half century

Moellering, R. C. (2012) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkr437 · Cited by 236

Novel Ribosomal Mutations in Staphylococcus aureus Strains Identified through Selection with the Oxazolidinones Linezolid and Torezolid (TR-700)

Locke, J. B., Hilgers, M. T., & Shaw, K. J. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00871-09 · Cited by 207

In Vitro Activity of TR-700, the Antibacterial Moiety of the Prodrug TR-701, against Linezolid-Resistant Strains

Shaw, K. J., Poppe, S. M., Schaadt, R. D., Brown‐Driver, V., Finn, J., Pillar, C. M., Shinabarger, D. L., & Zurenko, G. E. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00859-08 · Cited by 180

Structure-Activity Relationships of Diverse Oxazolidinones for Linezolid-Resistant Staphylococcus aureus Strains Possessing the cfr Methyltransferase Gene or Ribosomal Mutations

Locke, J. B., Finn, J., Hilgers, M. T., Morales, G., Rahawi, S., Kedar, G. C., Picazo, J. J., Im, W., Shaw, K. J., & Stein, J. L. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00663-10 · Cited by 153

Discovery of torezolid as a novel 5-hydroxymethyl-oxazolidinone antibacterial agent

Im, W. B., Choi, S. H., Park, J., Choi, S. H., Finn, J., & Yoon, S. (2011) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2011.01.014 · Cited by 139

Mutations in Ribosomal Protein L3 Are Associated with Oxazolidinone Resistance in Staphylococci of Clinical Origin

Locke, J. B., Hilgers, M. T., & Shaw, K. J. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01032-09 · Cited by 136

LEADER surveillance program results for 2006: an activity and spectrum analysis of linezolid using clinical isolates from the United States (50 medical centers)

Jones, R. N., Fritsche, T. R., Sader, H. S., & Ross, J. E. (2007) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2007.06.004 · Cited by 125

In Vitro Activity of TR-700, the Active Ingredient of the Antibacterial Prodrug TR-701, a Novel Oxazolidinone Antibacterial Agent

Schaadt, R. D., Sweeney, D., Shinabarger, D. L., & Zurenko, G. E. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00228-09 · Cited by 117

Transcriptional and Translational Control of the mlr Operon, Which Confers Resistance to Seven Classes of Protein Synthesis Inhibitors

Smith, L. K., & Mankin, A. S. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01583-07 · Cited by 115

Pulmonary Disposition of Tedizolid following Administration of Once-Daily Oral 200-Milligram Tedizolid Phosphate in Healthy Adult Volunteers

Housman, S. T., Pope, J. S., Russomanno, J. H., Salerno, E., Shore, E. T., Kuti, J. L., & Nicolau, D. P. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.05354-11 · Cited by 105

Improving known classes of antibiotics: an optimistic approach for the future

Bush, K. (2012) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2012.06.003 · Cited by 100

Activity of oxazolidinone TR-700 against linezolid-susceptible and -resistant staphylococci and enterococci

Livermore, D. M., Mushtaq, S., Warner, M., & Woodford, N. (2009) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkp002 · Cited by 89

In Vitro Activity and Microbiological Efficacy of Tedizolid (TR-700) against Gram-Positive Clinical Isolates from a Phase 2 Study of Oral Tedizolid Phosphate (TR-701) in Patients with Complicated Skin and Skin Structure Infections

Prokocimer, P., Bien, P. A., DeAnda, C., Pillar, C. M., & Bartizal, K. F. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00458-12 · Cited by 89

Comparative In Vitro Antimicrobial Activities of Torezolid (TR-700), the Active Moiety of a New Oxazolidinone, Torezolid Phosphate (TR-701), Determination of Tentative Disk Diffusion Interpretive Criteria, and Quality Control Ranges

Brown, S. D., & Traczewski, M. M. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01569-09 · Cited by 84

Elevated Linezolid Resistance in Clinical cfr -Positive Staphylococcus aureus Isolates Is Associated with Co-Occurring Mutations in Ribosomal Protein L3

Locke, J. B., Morales, G., Hilgers, M. T., Kedar, G. C., Rahawi, S., Picazo, J. J., Shaw, K. J., & Stein, J. L. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00714-10 · Cited by 77

Tedizolid (TR-701): a new oxazolidinone with enhanced potency

Kanafani, Z. A., & Corey, G. R. (2012) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2012.660250 · Cited by 68

Management of serious meticillin-resistant Staphylococcus aureus infections: what are the limits?

Gould, I. M., Cauda, R., Esposito, S., Gudiol, F., Mazzei, T., & Garau, J. (2011) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2010.10.030 · Cited by 65

Genetic Environment and Stability of cfr in Methicillin-Resistant Staphylococcus aureus CM05

Locke, J. B., Rahawi, S., LaMarre, J. M., Mankin, A. S., & Shaw, K. J. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.05420-11 · Cited by 65

Low Fitness Cost of the Multidrug Resistance Gene cfr

LaMarre, J. M., Locke, J. B., Shaw, K. J., & Mankin, A. S. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00153-11 · Cited by 64

Cellular pharmacokinetics and intracellular activity of torezolid (TR-700): studies with human macrophage (THP-1) and endothelial (HUVEC) cell lines

Lemaire, S., Françoise Van Bambeke, A., Appelbaum, P. C., & Tulkens, P. M. (2009) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkp267 · Cited by 60

LEADER Surveillance program results for 2010: an activity and spectrum analysis of linezolid using 6801 clinical isolates from the United States (61 medical centers)

Flamm, R. K., Farrell, D. J., Mendes, R. E., Ross, J. E., Sader, H. S., & Jones, R. N. (2012) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2012.05.012 · Cited by 51

Distinguishing On-Target versus Off-Target Activity in Early Antibacterial Drug Discovery Using a Macromolecular Synthesis Assay

Cunningham, M. L., Kwan, B. P., Nelson, K. J., Bensen, D. C., & Shaw, K. J. (2013) · SLAS DISCOVERY · doi:10.1177/1087057113487208 · Cited by 40

TR-700 in vitro activity against and resistance mutation frequencies among Gram-positive pathogens

Jones, R., Moet, G., Sader, H. S., Mendes, R. E., & Castanheira, M. (2009) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkp021 · Cited by 39

The Chemistry of Peptidyltransferase Center-Targeted Antibiotics: Enzymatic Resistance and Approaches to Countering Resistance

McCusker, K. P., & Fujimori, D. G. (2011) · ACS Chemical Biology · doi:10.1021/cb200418f · Cited by 32

Comparative In Vitro Activities of Torezolid (DA-7157) against Clinical Isolates of Aerobic and Anaerobic Bacteria in South Korea

Yum, J. H., Choi, S. H., Yong, D., Chong, Y., Im, W. B., Rhee, D., & Lee, K. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00728-10 · Cited by 30

Comparative Activities of TR-700 (Torezolid) against Staphylococcal Blood Isolates Collected in Spain

Betriú, C., Morales, G., Rodríguez-Avial, I., Culebras, E., Gómez, M., López, F., & Picazo, J. J. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01653-09 · Cited by 24

Activity of novel oxazolidinones against Nocardia brasiliensis growing within THP-1 macrophages

Cabrera, L. V., Espinoza-González, N. A., Welsh, O., Ocampo‐Candiani, J., & Castro‐Garza, J. (2009) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkp314 · Cited by 15

Resistance to linezolid in a methicillin-susceptible Staphylococcus aureus clinical isolate without previous exposure to oxazolidinones

Quiles-Melero, I., García-Perea, A., de Pablos, M., Gómez-Gil, R., & Mingorance, J. (2012) · International Journal of Medical Microbiology · doi:10.1016/j.ijmm.2012.03.001 · Cited by 12

Mechanisms of Antibiotic Resistance

Munita, J. M., & Arias, C. A. (2016) · Microbiology Spectrum · doi:10.1128/microbiolspec.vmbf-0016-2015 · Cited by 2,782

Antibiotic resistance in Staphylococcus aureus. Current status and future prospects

Foster, T. J. (2017) · FEMS Microbiology Reviews · doi:10.1093/femsre/fux007 · Cited by 930

A novel gene, optrA , that confers transferable resistance to oxazolidinones and phenicols and its presence in Enterococcus faecalis and Enterococcus faecium of human and animal origin

Wang, Y., Lv, Y., Cai, J., Schwarz, Š., Cui, L., Hu, Z., Zhang, R., Li, J., Zhao, Q., He, T., et al. (2015) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkv116 · Cited by 546

Antibiotic Resistance and the MRSA Problem

Vestergaard, M. R., Frees, D., & Ingmer, H. (2019) · Microbiology Spectrum · doi:10.1128/microbiolspec.gpp3-0057-2018 · Cited by 540

Mechanisms of antibiotic resistance

Munita, J. M., & Arias, C. A. (2016) · Virulence Mechanisms of Bacterial Pathogens · doi:10.1128/9781555819286.ch17 · Cited by 421

Tedizolid: A Novel Oxazolidinone with Potent Activity Against Multidrug-Resistant Gram-Positive Pathogens

Zhanel, G. G., Love, R., Adam, H. J., Golden, A., Zelenitsky, S. A., Schweizer, F., Gorityala, B. K., Lagacé-Wiens, P. R. S., Rubinstein, E., Walkty, A. J., et al. (2015) · Drugs · doi:10.1007/s40265-015-0352-7 · Cited by 186

Results of the Surveillance of Tedizolid Activity and Resistance Program: in vitro susceptibility of Gram-positive pathogens collected in 2011 and 2012 from the United States and Europe

Sahm, D. F., Deane, J., Bien, P. A., Locke, J. B., Zuill, D. E., Shaw, K. J., & Bartizal, K. F. (2014) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2014.08.011 · Cited by 73

New and old oxazolidinones: tedizolid vs. linezolid

Dekhnich, A. V., & Хачатрян, Н. Н. (2017) · DOAJ (DOAJ: Directory of Open Access Journals)

Tedizolid

Fernando, S. A., Shahabi-Sirjani, A., & Gottlieb, T. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-820472-6.00206-1

Early Experience with Tedizolid: Clinical Efficacy, Pharmacodynamics, and Resistance

Rybak, J. M., Marx, K. R., & Martin, C. A. (2014) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/phar.1491 · Cited by 52